Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

Application of a Chemotherapy Standard Form in Patients with Breast Cancer: Comparison of Private and Public Centers

Mahsa Rouhani 1 , Maryam Mousavi 2 , * , Mohammad Mahdi Kooshyar 3 , Soodabeh Shahidsales 4 , Yasha Makhdoumi 4 , Amir Amirabadi 5 and Sepideh Elyasi 1 , **
Authors Information
1 Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
2 Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, Tehran, Iran
3 Department of Hematology and Oncology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
4 Cancer Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
5 Solid Tumors Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Corresponding Authors:
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: August 2018, 13 (3); e13806
  • Published Online: August 28, 2018
  • Article Type: Research Article
  • Received: October 7, 2016
  • Revised: May 21, 2017
  • Accepted: August 27, 2017
  • DOI: 10.5812/jjnpp.13806

To Cite: Rouhani M, Mousavi M, Kooshyar M M, Shahidsales S, Makhdoumi Y, et al. Application of a Chemotherapy Standard Form in Patients with Breast Cancer: Comparison of Private and Public Centers, Jundishapur J Nat Pharm Prod. 2018 ; 13(3):e13806. doi: 10.5812/jjnpp.13806.

Copyright © 2018, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Muller T. Typical medication errors in oncology: analysis and prevention strategies. Onkologie. 2003;26(6):539-44. doi: 10.1159/000074148. [PubMed: 14709927].
  • 2. Gilbar PJ. Preventing medication errors in cancer chemotherapy referred to rural and remote hospitals. Aust J Rural Health. 2001;9(1):47-51. doi: 10.1046/j.1440-1584.2001.00321.x. [PubMed: 11703267].
  • 3. National Coordinating Council for Medication Error Reporting and Prevention . NCC MERP index for categorizing medication errors. 2001. Available from: http://www.nccmerp.org.
  • 4. Phillips J, Beam S, Brinker A, Holquist C, Honig P, Lee LY, et al. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm. 2001;58(19):1835-41. [PubMed: 11596700].
  • 5. Womer RB, Tracy E, Soo-Hoo W, Bickert B, DiTaranto S, Barnsteiner JH. Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gains. J Clin Oncol. 2002;20(24):4705-12. doi: 10.1200/JCO.2002.04.108. [PubMed: 12488417].
  • 6. Garcia-Alonso A. Improving the chemotherapy process and service to cancer patients. Risk Manag Healthc Policy. 2011;4:41-5. doi: 10.2147/RMHP.S16059. [PubMed: 22312226]. [PubMed Central: PMC3270930].
  • 7. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997;277(4):307-11. doi: 10.1001/jama.1997.03540280045032. [PubMed: 9002493].
  • 8. Gandhi TK, Bartel SB, Shulman LN, Verrier D, Burdick E, Cleary A, et al. Medication safety in the ambulatory chemotherapy setting. Cancer. 2005;104(11):2477-83. doi: 10.1002/cncr.21442. [PubMed: 16245353].
  • 9. Kohn LT. The Institute of medicine report on medical error: overview and implications for pharmacy. Am J Health Syst Pharm. 2001;58(1):63-6. [PubMed: 11194137].
  • 10. Markert A, Thierry V, Kleber M, Behrens M, Engelhardt M. Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment. Int J Cancer. 2009;124(3):722-8. doi: 10.1002/ijc.23991. [PubMed: 18989899].
  • 11. Schulmeister L. Preventing chemotherapy errors. Oncologist. 2006;11(5):463-8. doi: 10.1634/theoncologist.11-5-463. [PubMed: 16720846].
  • 12. Kohler D, Goldspiel BR, Montello M, Ignoffo RJ. ASHP guidelines on preventing medication errors with antineoplastic agents. Am J Health Syst Pharm. 2002;59(17):1648-68.
  • 13. Cohen MR, Davis NM. Developing safe and effective preprinted physician's order forms. Hosp Pharm. 1992;27(6):508-513, 528. [PubMed: 10118594].
  • 14. Goldspiel BR, DeChristoforo R, Daniels CE. A continuous-improvement approach for reducing the number of chemotherapy-related medication errors. Am J Health Syst Pharm. 2000;57 Suppl 4:S4-9. [PubMed: 11148943].
  • 15. Olsen M. Order sheets help prevent chemotherapy administration errors. Oncol Nurs Forum. 1997;24(5):802-3. [PubMed: 9244865].
  • 16. Opfer KB, Wirtz DM, Farley K. A chemotherapy standard order form: preventing errors. Oncol Nurs Forum. 1999;26(1):123-8. [PubMed: 9921575].
  • 17. Thorn DB, Sexton MG, Lemay AP, Sarigianis JS, Melita DD, Gustafson NJ. Effect of a cancer chemotherapy prescription form on prescription completeness. Am J Hosp Pharm. 1989;46(9):1802-6. [PubMed: 2801713].
  • 18. Pastel DA, Fay P, Lee D. Effect of implementing a cancer chemotherapy order form on prescribing habits for parenteral antineoplastics. Hosp Pharm. 1993;28(12):1192-5. [PubMed: 10130616].
  • 19. Herdrich K, Weinberger H. Selected schedules in the therapy of malignant tumors. Baxter; 2013. p. 164-95.
  • 20. Kouno T, Katsumata N, Mukai H, Ando M, Watanabe T. Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan. Jpn J Clin Oncol. 2003;33(6):309-13. doi: 10.1093/jjco/hyg062. [PubMed: 12913086].
  • 21. Dhamija M, Kapoor G, Juneja A. Infusional chemotherapy and medication errors in a tertiary care pediatric cancer unit in a resource-limited setting. J Pediatr Hematol Oncol. 2014;36(7):e412-5. doi: 10.1097/MPH.0000000000000044. [PubMed: 24136029].
  • 22. Rinke ML, Shore AD, Morlock L, Hicks RW, Miller MR. Characteristics of pediatric chemotherapy medication errors in a national error reporting database. Cancer. 2007;110(1):186-95. doi: 10.1002/cncr.22742. [PubMed: 17530619].
  • 23. Fyhr A, Akselsson R. Characteristics of medication errors with parenteral cytotoxic drugs. Eur J Cancer Care (Engl). 2012;21(5):606-13. doi: 10.1111/j.1365-2354.2012.01331.x. [PubMed: 22335508]. [PubMed Central: PMC3509217].
  • 24. Walsh KE, Dodd KS, Seetharaman K, Roblin DW, Herrinton LJ, Von Worley A, et al. Medication errors among adults and children with cancer in the outpatient setting. J Clin Oncol. 2009;27(6):891-6. doi: 10.1200/JCO.2008.18.6072. [PubMed: 19114695].
  • 25. Eslami S, Abu-Hanna A, de Keizer NF. Evaluation of outpatient computerized physician medication order entry systems: a systematic review. J Am Med Inform Assoc. 2007;14(4):400-6. doi: 10.1197/jamia.M2238. [PubMed: 17460137]. [PubMed Central: PMC2244893].
  • 26. Corrie PG. Cytotoxic chemotherapy: clinical aspects. Medicine. 2008;36(1):24-8. doi: 10.1016/j.mpmed.2007.10.012.
  • 27. Bardal SK, Waechter JE, Martin DS. Applied pharmacology. St. Louis: Elsevier/Saunders; 2011. p. 31-2.
  • 28. Dumasia L, Harris E, Drelichman A. Quality performance improvement with the implementation of standard chemotherapy order forms. J Oncol Pract. 2006;2(3):104-7. doi: 10.1200/JOP.2006.2.3.104. [PubMed: 20871708]. [PubMed Central: PMC2794599].
  • 29. Kloth D. Guide to the prevention of chemotherapy medication errors. 1 ed. 2009. p. 1-17.
  • 30. Schwappach DL, Wernli M. Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature. Eur J Cancer Care (Engl). 2010;19(3):285-92. doi: 10.1111/j.1365-2354.2009.01127.x. [PubMed: 19708929].
  • 31. Franneby U, Sandblom G, Nyren O, Nordin P, Gunnarsson U. Self-reported adverse events after groin hernia repair, a study based on a national register. Value Health. 2008;11(5):927-32. doi: 10.1111/j.1524-4733.2008.00330.x. [PubMed: 18489521].
  • 32. Schwappach DL. "Against the silence": development and first results of a patient survey to assess experiences of safety-related events in hospital. BMC Health Serv Res. 2008;8:59. doi: 10.1186/1472-6963-8-59. [PubMed: 18366707]. [PubMed Central: PMC2279127].
  • 33. Weissman JS, Schneider EC, Weingart SN, Epstein AM, David-Kasdan J, Feibelmann S, et al. Comparing patient-reported hospital adverse events with medical record review: do patients know something that hospitals do not? Ann Intern Med. 2008;149(2):100-8. doi: 10.7326/0003-4819-149-2-200807150-00006. [PubMed: 18626049].
  • 34. Schulmeister L. Chemotherapy medication errors: descriptions, severity, and contributing factors. Oncol Nurs Forum. 1999;26(6):1033-42. [PubMed: 10420421].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments